Truist Financial Corp cut its stake in shares of Stryker Co. (NYSE:SYK – Free Report) by 2.0% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 120,610 shares of the medical technology company’s stock after selling 2,444 shares during the period. Truist Financial Corp’s holdings in Stryker were worth $41,037,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Koshinski Asset Management Inc. purchased a new position in Stryker in the 1st quarter valued at about $795,000. Envestnet Portfolio Solutions Inc. boosted its stake in shares of Stryker by 43.1% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 18,491 shares of the medical technology company’s stock worth $6,617,000 after acquiring an additional 5,565 shares during the last quarter. Norden Group LLC purchased a new stake in shares of Stryker during the first quarter worth approximately $4,027,000. International Assets Investment Management LLC acquired a new position in Stryker in the 1st quarter valued at $21,970,000. Finally, BI Asset Management Fondsmaeglerselskab A S lifted its holdings in Stryker by 38.5% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 19,796 shares of the medical technology company’s stock valued at $7,084,000 after purchasing an additional 5,502 shares in the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, VP M Kathryn Fink sold 7,347 shares of the company’s stock in a transaction that occurred on Tuesday, September 17th. The shares were sold at an average price of $366.98, for a total transaction of $2,696,202.06. Following the sale, the vice president now directly owns 10,042 shares of the company’s stock, valued at approximately $3,685,213.16. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, VP M Kathryn Fink sold 7,347 shares of the business’s stock in a transaction on Tuesday, September 17th. The stock was sold at an average price of $366.98, for a total transaction of $2,696,202.06. Following the completion of the transaction, the vice president now directly owns 10,042 shares of the company’s stock, valued at approximately $3,685,213.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Glenn S. Boehnlein sold 20,000 shares of the stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $333.00, for a total value of $6,660,000.00. Following the completion of the sale, the chief financial officer now directly owns 2,852 shares in the company, valued at approximately $949,716. The disclosure for this sale can be found here. Over the last quarter, insiders sold 220,068 shares of company stock valued at $71,811,372. 5.90% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Read Our Latest Stock Report on Stryker
Stryker Stock Down 0.6 %
Stryker stock opened at $355.11 on Thursday. The company has a market capitalization of $135.28 billion, a PE ratio of 40.54, a price-to-earnings-growth ratio of 2.78 and a beta of 0.91. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.95 and a current ratio of 1.68. Stryker Co. has a fifty-two week low of $249.98 and a fifty-two week high of $374.63. The firm has a 50 day moving average price of $348.90 and a 200 day moving average price of $343.12.
Stryker (NYSE:SYK – Get Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The medical technology company reported $2.81 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.02. Stryker had a return on equity of 22.89% and a net margin of 16.12%. The business had revenue of $5.42 billion during the quarter, compared to analysts’ expectations of $5.40 billion. During the same period in the previous year, the firm posted $2.54 earnings per share. The company’s revenue was up 8.5% on a year-over-year basis. Research analysts expect that Stryker Co. will post 12 earnings per share for the current year.
Stryker Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Monday, September 30th will be given a dividend of $0.80 per share. The ex-dividend date is Monday, September 30th. This represents a $3.20 annualized dividend and a dividend yield of 0.90%. Stryker’s dividend payout ratio is presently 36.53%.
About Stryker
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Further Reading
- Five stocks we like better than Stryker
- Breakout Stocks: What They Are and How to Identify Them
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Election Stocks: How Elections Affect the Stock Market
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- 3 REITs to Buy and Hold for the Long Term
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.